Sunday, August 23, 2026
21 C
Bengaluru

Frontline Managers

[wpfilebase tag=file id=62 tpl=download-button /]

Inside this Issue

1. Parle-G: Still Number One by Vivek Hattangadi

How this 80 year old brand still has 80 percent market share.

2. The University of Pharma Sales by Raja Reddy

What the author learned about success and life on his journey from Medical Representative to Group Product Manager.

3. Nine Accountability Boosters for Frontline Managers by K. Hariram

9 habits that will inspire the confidence of your team members in your Leadership.

4. Bridging the Trust Deficit by Satish Kota

Indian Pharma has contributed immensely to society but needs an image makeover to change negative perceptions.

5. Impact of Frontline Leadership on Efficiency: A Case Study by P. S. Parameswaran

The actions of the Frontline Manager, more than anything else, has a direct impact on how employees perform.

6. Cost-Effective Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

7. Smart Pills by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, Mahendra Kumar Rai

Are ingestible sensors the next big thing in patient adherence?

Hot this week

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Topics

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img